Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1988-1-11
|
pubmed:abstractText |
This is the final report of a study of single dose pharmacokinetic parameters of nortriptyline in children and adolescents 5 to 16 years old (N = 64). The data were analyzed separately for the 5- to 12-year-olds (N = 41) and for the 13- to 16-year-olds (N = 32). The results confirm the preliminary findings of the similarity of the pharmacology of nortriptyline between the pediatric and adult age groups with respect to a logarithmically linear rate of elimination and a wide interindividual rate of metabolism. The 5- to 12-year-olds had a significantly shorter mean half-life and a significantly greater mean apparent oral clearance than the 13- to 16-year-olds. The mean half-life in the 5- to 12-year-olds was 20.8 +/- 7.2 (range, 11.2 to 42.5) hours and in the 13- to 16-year-olds was 31.1 +/- 19.8 (range, 14.2 to 89.4) hours. A twice a day dosage regimen is recommended for the entire 5- to 16-year-old group based on their range of half-lives.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0271-0749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-3
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3680602-Adolescent,
pubmed-meshheading:3680602-Age Factors,
pubmed-meshheading:3680602-Child,
pubmed-meshheading:3680602-Child, Preschool,
pubmed-meshheading:3680602-Female,
pubmed-meshheading:3680602-Half-Life,
pubmed-meshheading:3680602-Humans,
pubmed-meshheading:3680602-Male,
pubmed-meshheading:3680602-Nortriptyline,
pubmed-meshheading:3680602-Reference Values
|
pubmed:year |
1987
|
pubmed:articleTitle |
Child and adolescent nortriptyline single dose pharmacokinetic parameters: final report.
|
pubmed:affiliation |
Childhood Affective Disorders Program, William S. Hall Psychiatric Institute, Columbia, South Carolina 29202.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|